Martin Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-107,759
Closed -$10.2M 47
2019
Q1
$10.2M Sell
107,759
-177
-0.2% -$15.5K 2.65% 18
2018
Q4
$6.92M Sell
107,936
-1,276
-1% -$94.2K 2.23% 28
2018
Q3
$9.77M Sell
109,212
-18,533
-15% -$1.64M 2.62% 21
2018
Q2
$10.1M Buy
127,745
+8,829
+7% +$733K 2.55% 23
2018
Q1
$10.6M Buy
118,916
+8,200
+7% +$787K 2.69% 23
2017
Q4
$16.1M Hold
110,716
4.51% 4
2017
Q3
$16.1M Sell
110,716
-2,588
-2% -$353K 4.51% 4
2017
Q2
$14.7M Sell
113,304
-3,082
-3% -$378K 4.15% 5
2017
Q1
$14.5M Sell
116,386
-40,069
-26% -$4.8M 4.09% 4
2016
Q4
$18.1M Sell
156,455
-51,147
-25% -$5.7M 3.44% 6
2016
Q3
$21.7M Sell
207,602
-7,889
-4% -$854K 3.57% 9
2016
Q2
$21.3M Sell
215,491
-26,050
-11% -$2.69M 3.55% 9
2016
Q1
$24.2M Sell
241,541
-6,891
-3% -$710K 3.77% 7
2015
Q4
$29.8M Sell
248,432
-10,238
-4% -$1.18M 4.72% 3
2015
Q3
$28M Sell
258,670
-34,291
-12% -$4.26M 4.51% 4
2015
Q2
$33.9M Sell
292,961
-7,043
-2% -$805K 4.86% 4
2015
Q1
$34.6M Buy
300,004
+37,099
+14% +$4.43M 4.82% 2
2014
Q4
$29.4M Sell
262,905
-11,184
-4% -$1.18M 4.84% 2
2014
Q3
$26M Sell
274,089
-9,809
-3% -$885K 4.59% 3
2014
Q2
$24.4M Buy
283,898
+1,246
+0.4% +$94.8K 4.38% 5
2014
Q1
$19.7M Sell
282,652
-2,400
-0.8% -$190K 3.75% 9
2013
Q4
$24.1M Buy
285,052
+826
+0.3% +$65.4K 4.44% 3
2013
Q3
$21.9M Sell
284,226
-19,884
-7% -$1.39M 4.75% 3
2013
Q2
$17.8M Buy
+304,110
New +$18.3M 4.2% 3

Other funds holding CELG

Martin Investment Management's CELG Position: Q2 2019 in Review

Martin Investment Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 107,759 shares — an estimated $10.2M sold.

Martin Investment Management first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $34.6M in Q1 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Martin Investment Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Martin Investment Management sold 107,759 Celgene Corp shares in Q2 2019, an estimated $10.2M.
  • Martin Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Martin Investment Management's Celgene Corp position peaked at $34.6M in Q1 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Martin Investment Management's 13F filing for Q2 2019, filed 7 Aug 2019.